SOVREMENNAYA PEDIATRIYA.2016.6(78):27-32; doi 10.15574/SP.2016.78.27 

Justification use of magnesium in pediatric patients (review) 

Marushko Iu. V., Hyschak T. V.

Bogomolets National Medical University, Kiev, Ukraine 

Among the pathologies of element status in Ukraine's population magnesium deficiency occupies a leading position. Very often this deficiency appears in childhood and adolescence, when due to intensive child development increased magnesium need not meet his admission with food. The article presents literature data and the results of individual studies authors demonstrate feasibility of determining the level of magnesium in many somatic diseases and the need for timely correction of magnesium deficiency. Correction of magnesium deficiency by using organic salts of magnesium and pyridoxine (Magne-B₆^®) improves cellular metabolism and energy supply, stabilizing the membrane and the formation of physiological conditions for the perception of body cells specific treatment of the underlying disease. The use of Magne-B₆^® base can influence the pathogenesis of many diseases associated with magnesium deficiency, with disturbances of the energy and electrolyte metabolism and help restore adaptive reserves of the organism.

Key words: magnesium deficiency, children, Magne-B₆^®.

REFERENCES

1. Akarachkova ES, Vershinina SV, Kotova OV, Ryabokon IV. 2014. Algoritm diagnostiki, lecheniya i profilaktiki stressa i stress-svyazannyih rasstroystv u detey i podrostkov. Voprosyi praktich pediatrii. 6: 24—31.

2. Akarachkova ES, Vershinina SV. 2013. Rol magniya v protsessah neyroprotektsii i neyroplastichnosti. Zhurnal nevrologii i psihiatrii im SS Korsakova. 2: 80—83.

3. Arushanyan EB, Beyer EV. 2012. Gormon mozgovoy zhelezyi epifiza melatonin — universalnyiy estestvennyiy adaptogen. Uspehi fiziol nauk. 43; 2: 82—100.

4. Babanov SA. 2015. Mag po imeni Magniy. Novaya apteka. 4: 70.

5. Burchinskiy SG. 2013. Melatonin i ego vozmozhnosti v nevrologicheskoy praktike. Ukrainskyi visn psykhonevrol. 21; 1(74): 112—117.

6. Hyshchak TV, Marushko YuV. 2011. Obmin mahniiu u ditei ta rol defitsytu mahniiu u klinichnii praktytsi. Sovremennaya pediatriya. 5(39): 89—93.

7. Gromova OA. 2014. Defitsit magniya kak problema sovremennogo pitaniya u detey i podrostkov. Pediatricheskaya farmakol. 1: 20—30.

8. Gromova OA, Torshin IYu, Rudakov KV. 2014. Sistematicheskiy analiz magniyzavisimyih mitohondrialnyih belkov. Kardiologiya. 9: 86—92.

9. Karkashadze GA, Namazova-Baranova LS, Mamedyarov AM et al. 2014. Defitsit magniya v detskoy nevrologii: chto nuzhno znat pediatru? Voprosyi sovr pediatrii. 5: 17—25.

10. Gromova OA, Torshin IYu, Yudina NV et al. 2014. Defitsit magniya i narusheniya regulyatsii tonusa sosudov. Kardiologiya. 7: 66—72.

11. Vyatkina IS, Labyigina AV, Suturina LV et al. 2014. Defitsit magniya i pokazateli trevozhnosti u devushek-studentok. Reproduktivnoe zdorove detey i podrostkov. 2: 94—99.

12. Tarasov EA, Blinov DV, Zimovina UV, Sandakova EA. 2015. Defitsit magniya i stress: voprosyi vzaimosvyazi, testyi dlya diagnostiki i podhodyi k terapii. Terapevticheskiy arh. 9: 114—122.

13. Gromova OA, Fedotova LE, Kalacheva AG et al. 2013. Defitsit magniya kak problema stressa i dezadaptatsii u detey. Pediatriya. 5: 110—121.

14. Gromova OA, Kalacheva AG, Torshin IYu et al. 2014. Diagnostika defitsita magniya. Kontsentratsii magniya v biosubstratah v norme i pri razlichnoy patologi. Kardiologiya. 10: 63—71.

15. Gromova OA, Torshin IYu, Kalacheva AG et al. 2009. Dinamika kontsentratsii magniya v krovi posle priema razlichnyih magnesoderzhaschih preparatov. Farmateka. 10: 63—68.

16. Drapkina OM, Gegenava BB. 2014.Defitsit magniya v kardiologii. Terapevticheskiy arhiv. 12: 104—106.

17. Martyinov AI, Urlaeva IV, Akatova EV, Nikolin OP. 2014. Znachenie defitsita magniya v kardiologii. Consilium medicum. 1: 43—46.

18. Gromova OA, Torshin IYu, Volkov AYu, Sherbo SN. 2014. Znachenie dlya klinicheskoy praktiki ranney diagnostiki defitsita magniya pri opredelenii ego v razlichnyih biosubstratah. Rossiyskiy vestn akushera-ginekologa. 5: 101—110.

19. Gromova OA, Kalacheva AG, Torshin IYu et al. 2013. Kaliysberegayuschie svoystva magniya. Kardiologiya. 10: 38—48.

20. Maydannik VG, SmIyan OI, Binda TP, SavelEva-Kulik NO. 2013. KlInIko-patogenetichna harakteristika vegetativnih disfunktsIy ta Yih lIkuvannya u dItey. Navchalniy posIbnik. Za red VG Maydannika. Sumi, Sumskiy derzh Un-t: 173.

21. Nemkova SA, Maslova OI, Zavadenko NN et al. 2015. Kompleksnaya diagnostika i korrektsiya narusheniy sna u detey. Pediatricheskaya farmakologiya. 2: 180—189.

22. Marushko YuV, Hyshchak TV. 2013. Efektyvnist zastosuvannia Mahne-V6 pry astenichnomu syndromi i porushenniakh nichnoho snu u ditei. Sovremennaia pedyatryia. 6(53): 37—44.

23. Marushko YuV, Hyshchak TV. 2013. Korektsiia defitsytu mahniiu u ditei ta pidlitkiv z astenichnym syndromom. Problemni pytannia diahnostyky ta likuvannia ditei z somatychnoiu patolohiieiu. Materialy nauk-prakt konf z mizhnar uch. Kharkiv, 28 ber: 20—22.

24. Marushko YuV, Hyshchak TV. 2012. Korektsiia nedostatnosti mahniiu u ditei ta pidlitkiv z astenichnym syndromom ta pervynnoiu arterialnoiu hipertenziieiu. Metodychni rekomendatsii dlia likariv. Kyiv: 29.

25. Marushko YuV, Hyshchak TV. 2014. Systemni mekhanizmy adaptatsii. Stres u ditei. Monohrafiia. Kyiv: 158.

26. Marushko YuV, Hyshchak TV. 2014. Systemni mekhanizmy adaptatsii. Stres u ditei. Monohrafiia. Kyiv-Khmelnytskyi, pryvatna drukarnia FO-P Storozhuk OV: 140.

27. Mubarakshina OA, Somova MN. 2014. Preparatyi magniya v kompleksnoy terapii i profilaktike serdechno-sosudistyih zabolevaniy. Farmateka. 9: 55—58.

28. Kalacheva AG, Gromova OA, Kerimkulova NV et al. 2012. Narusheniya formirovaniya soedinitelnoy tkani u detey kak sledstvie defitsita magniya. Lechaschiy vrach. 3: 59—64.

29. Gromova YuA, Torshin IYu, Kalacheva AG, Grishina TR. 2016. O sinergizme kaliya i magniya v podderzhanii funktsii mIokarda. Kardiologiya. 3: 73—80.

30. Akarachkova ES, Vershinina SV, Kotova OV, Ryabokon IV. 2013. Osnovyi terapii i profilaktiki stressa i ego posledstviy u detey i podrostkov. Voprosyi sovr pediatrii. 3: 38—44.

31. Gromova OA, Egorova EYu, Torshin IYu et al. [i dr.] 2010. Perspektivyi primeneniya magniya v pediatrii i detskoy nevrologi. Zhurnal Pediatrii im GN Speranskogo. 7: 9—14.

32. Shkolnikova MA, Kleymenova NI, Dikevich EP, Erastova EK. 2011. Primenenie preparatov magniya pri lechenii narusheniy ritma serdtsa u detey. Rossiyskiy vestn perinatol i pediatrii. 2: 63-68.

33. Rahmanov RS, Razgulin SA, Tarasov AV. 2014. Otsenka vitaminno-mineralnogo statusa i gumoralnogo immuniteta yunoshey pri psihosotsialnoy adaptatsii i akklimatizatsii. Meditsinskiy alm. 2: 149—151.

34. Gromova OA, Fedotova LE, Grishina TR et al. 2014. Rol magniya v formirovanii metabolicheskogo sindroma, korrektsii izbyitochnogo vesa i ozhireniya u detey i podrostkov. Pediatriya. 2: 123—133.

35. Makarova TP, Habibrahmanova ZR, Sadyikova DI, Chilikina YuM. 2012. Sostoyanie elementnogo gomeostaza u detey i podrostkov s essentsialnoy arterialnoy gipertenziey. Kazanskiy med zhurn. 2: 184—190.

36. Spasov AA, Zheltova A, Haritonova MV. 2012. Magniy i okislitelnyiy stress. Rossiyskiy fiziologich zhurn. 7: 915—923.

37. Spasov AA, Haritonova MV, Iezhitsa IN et al. 2012. Funktsionalnyie rezervyi serdtsa v usloviyah alimentarnogo defitsita magniya. Kardiologiya. 10: 39—44.

38. Abbasi B. 2012. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 17(12): 1161—1169. PMid:23853635 PMCid:PMC3703169

39. Jin K, Kim TH, Kim YH, Kim YW. 2013. Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats. Korean J Intern Med. 28(2): 197—205. https://doi.org/10.3904/kjim.2013.28.2.197; PMid:23526071 PMCid:PMC3604610

40. Mortazavi M, Moeinzadeh F, Saadatnia M et al. 2013. Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur Neurol. 69(5): 309—316. https://doi.org/10.1159/000346427; PMid:23548855

41. Astor MC, Lovas K, Wolff AS et al. 2015. Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6. Endocr Connect. 4(4): 215—222. https://doi.org/10.1530/EC-15-0066; PMid:26273099 PMCid:PMC4566842

42. Coulter M, Colvin C, Korf B et al. 2015. Hypomagnesemia due to two novel TRPM6 mutations. J Pediatr Endocrinol Metab. 1: 28(11—12): 1373—1378.

43. Morales-Ruan Mdel C, Villalpando S, Garcia-Guerra A et al. 2012. Iron, zinc, copper and magnesium nutritional status in Mexican children aged 1 to 11 years. Slud Publica Mex. 54(2): 125—134. https://doi.org/10.1590/S0036-36342012000200008

44. Guerrero-Romero F, Rodriguez-Moran M, Hernandez-Ronquillo G et al. 2016. Low Serum Magnesium Levels and Its Association with High Blood Pressure in Children. J Pediatr. 168: 93-98. https://doi.org/10.1016/j.jpeds.2015.09.050; PMid:26490130

45. Sarrafzadegan N, Khosravi-Boroujeni H, Lotfizadeh M et al. 2016. Magnesium status and the metabolic syndrome: A systematic review and meta-analysis. Nutrition. 32(4): 409—417. https://doi.org/10.1016/j.nut.2015.09.014; PMid:26919891

46. Katayama K, Povalko N, Yatsuga S et al. 2015. New TRPM6 mutation and management of hypomagnesaemia with secondary hypocalcaemia. Brain Dev. 37(3): 292—298. https://doi.org/10.1016/j.braindev.2014.06.006; PMid:24985022

47. Rubio-Lopez N, Morales-Suarez-Varela M, Pico Y et al. 2016. Nutrient Intake and Depression Symptoms in Spanish Children: The ANIVA Study. Int J Environ Res Public Health. 22: 13—16. https://doi.org/10.3390/ijerph13030352

48. Rodriguez-Ramirez M, Simental-Mendia LE, Gonzalez-Ortiz M et al. 2015. Prevalence of Prehypertension in Mexico and Its Association With Hypomagnesemia. Am J Hypertens. 28(8): 1024—1030. https://doi.org/10.1093/ajh/hpu293; PMid:25618517

49. Rotter I, Kosik-Bogacka D, Dolegowska B et al. 2015. Relationship between serum magnesium concentration and metabolic and hormonal disorders in middle-aged and older men. Magnes Res. 28(3): 99—107. PMid:26507751

50. Zaher MM, Abdel-Salam M, Abdel-Salam R et al. 2016. Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis. Saudi J Kidney Dis Transpl. 27(2): 233—240. https://doi.org/10.4103/1319-2442.178205; PMid:26997375

51. Ozmen H, Akarsu S, Polat F, Cukurovali A. 2013. The levels of calcium and magnesium, and of selected trace elements, in whole blood and scalp hair of children with growth retardation. Iran J Pediatr. 23(2): 125—130. PMid:23724170 PMCid:PMC3663300

52. Tomaschitz A, Ritz E, Pieske B et al. 2014. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism. 63(1): 20—31. https://doi.org/10.1016/j.metabol.2013.08.016; PMid:2409563

53. Witkowski M, Hubert J, Mazur A. 2011. Methods of assessment of magnesium status in humans: a systematic review. Magnes Res. 24(4): 163—180. PMid:22064327